These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 620477)

  • 1. Methadone maintenance: plasma levels and therapeutic outcome.
    Holmstrand J; Anggård E; Gunne LM
    Clin Pharmacol Ther; 1978 Feb; 23(2):175-80. PubMed ID: 620477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-Methadone and D,L-methadone in methadone maintenance treatment: a comparison of therapeutic effectiveness and plasma concentrations.
    de Vos JW; Ufkes JG; Kaplan CD; Tursch M; Krause JK; van Wilgenburg H; Woodcock BG; Staib AH
    Eur Addict Res; 1998 Sep; 4(3):134-41. PubMed ID: 9742275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methadone plasma levels and persistent drug abuse in high dose maintenance patients.
    Tennant FS; Rawson RA; Cohen A; Tarver A; Clabough D
    Subst Alcohol Actions Misuse; 1983; 4(5):369-74. PubMed ID: 6670059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors predicting retention in treatment: 10-year experience of a methadone maintenance treatment (MMT) clinic in Israel.
    Peles E; Schreiber S; Adelson M
    Drug Alcohol Depend; 2006 May; 82(3):211-7. PubMed ID: 16219428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzodiazepine abuse in a methadone maintenance treatment clinic in Israel: characteristics and a pharmacotherapeutic approach.
    Bleich A; Gelkopf M; Weizman T; Adelson M
    Isr J Psychiatry Relat Sci; 2002; 39(2):104-12. PubMed ID: 12227225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methadone plasma levels and persistent drug abuse in high dose maintenance patients.
    Tennant FS; Rawson RA; Cohen A; Tarver A; Clabough D
    NIDA Res Monogr; 1984 Mar; 49():262-8. PubMed ID: 6434970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of methadone and its primary metabolite in 20 opiate addicts.
    de Vos JW; Geerlings PJ; van den Brink W; Ufkes JG; van Wilgenburg H
    Eur J Clin Pharmacol; 1995; 48(5):361-6. PubMed ID: 8641323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose, Plasma Level, and Treatment Outcome Among Methadone Patients in Shanghai, China.
    Jiang H; Hillhouse M; Du J; Pan S; Alfonso A; Wang J; Zhou Z; Yuan W; Ling W; Zhao M
    Neurosci Bull; 2016 Dec; 32(6):538-544. PubMed ID: 27612968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of methadone in maintenance clients who persist in illicit drug use.
    Bell J; Bowron P; Lewis J; Batey R
    Br J Addict; 1990 Dec; 85(12):1599-602. PubMed ID: 1981155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Withdrawal from methadone maintenance treatment. Reasons for not trying to quit methadone.
    Hiltunen AJ; Eklund C
    Eur Addict Res; 2002 Jan; 8(1):38-44. PubMed ID: 11818692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple substance use among heroin-dependent patients before and during attendance at methadone maintenance treatment program, Yunnan, China.
    Li L; Sangthong R; Chongsuvivatwong V; McNeil E; Li J
    Drug Alcohol Depend; 2011 Jul; 116(1-3):246-9. PubMed ID: 21282020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between plasma concentrations of the l-enantiomer of methadone and response to methadone maintenance treatment.
    Meini M; Moncini M; Daini L; Giarratana T; Scaramelli D; Chericoni S; Stefanelli F; Rucci P
    Eur J Pharmacol; 2015 Aug; 760():1-6. PubMed ID: 25891369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of methadone maintenance treatment utilization in a multisite cohort of illicit opioid users (OPICAN).
    Fischer B; Cruz MF; Patra J; Rehm J
    J Subst Abuse Treat; 2008 Apr; 34(3):340-6. PubMed ID: 17614236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of methadone dose contingencies on urinalysis test results of polydrug-abusing methadone-maintenance patients.
    Stitzer ML; Bickel WK; Bigelow GE; Liebson IA
    Drug Alcohol Depend; 1986 Dec; 18(4):341-8. PubMed ID: 3816530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic thresholds in methadone maintenance treatment: a receiver operating characteristic analysis.
    Hallinan R; Ray J; Byrne A; Agho K; Attia J
    Drug Alcohol Depend; 2006 Feb; 81(2):129-36. PubMed ID: 16026938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methadone-related deaths and mortality rate during induction into methadone maintenance, New South Wales, 1996.
    Zador DA; Sunjic SD
    Drug Alcohol Rev; 2002 Jun; 21(2):131-6. PubMed ID: 12188991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between maternal methadone dosage, maternal-neonatal methadone levels, and neonatal withdrawal.
    Doberczak TM; Kandall SR; Friedmann P
    Obstet Gynecol; 1993 Jun; 81(6):936-40. PubMed ID: 8497359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cocaine abuse in methadone maintenance patients is associated with low serum methadone concentrations.
    Tennant F; Shannon J
    J Addict Dis; 1995; 14(1):67-74. PubMed ID: 7632748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma levels and symptom complaints in patients maintained on daily dosage of methadone hydrochloride.
    Horns WH; Rado M; Goldstein A
    Clin Pharmacol Ther; 1975 Jun; 17(6):636-49. PubMed ID: 1139855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment.
    Stenbacka M; Beck O; Leifman A; Romelsjö A; Helander A
    Drug Alcohol Rev; 2007 Jan; 26(1):55-63. PubMed ID: 17364837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.